A Universal Tumor-Specific Promoter for Cancer Gene Therapy


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

An artificial double tandem tumor-specific promoter based on survivin and human telomerase reverse transcriptase gene promoters was constructed. Studies in in vitro and ex vivo therapeutic systems showed that the designed promoter exhibits a high activity in tumor cells, which is comparable to the activity of the CMV constitutive promoter.

作者简介

I. Alekseenko

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Institute of Molecular Genetics

编辑信件的主要联系方式.
Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997; Moscow, 123182

V. Pleshkan

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Institute of Molecular Genetics

Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997; Moscow, 123182

A. Sass

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997

O. Filyukova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997

E. Snezhkov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997

E. Sverdlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Institute of Molecular Genetics

Email: irina.alekseenko@mail.ru
俄罗斯联邦, Moscow, 117997; Moscow, 123182

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2018